Angiotensin-Converting Enzyme Inhibitors

All categories
DBCAT000415Therapeutic categoryC09AA

A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. A DrugBank category of 32 drugs. 15 of them are approved.

ATC classification
Part of
Agents Acting on the Renin-Angiotensin System
Also known as
ACE i · ACE Inhibitors · ACE Inhibitors, Plain · ACE-Inhibitors · ACEi
Drugs

and 7 more with a free account

What you can answer from here — as of May 21, 2021

32DrugsEach linked to its full drug card
Sign in
14Drug targetsEvery drug–target pair in the class, with bond type
Sign in
11,690Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
5Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Angiotensin-Converting Enzyme Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In